Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stryckmans

Showing results (131-140 of 131) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 131 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon GroupB Löwenberg, S Suciu, E Archimbaud, et al.
Pageof 14

Showing results (131-140 of 131) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 131 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon GroupB Löwenberg, S Suciu, E Archimbaud, et al.
Pageof 14